- The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura
-
Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N
- KMID: 2411961
- Gut Liver.
- 2016 May;10(3):356-361.
- doi: 10.5009/gnl14483
BACKGROUND/AIMS: The aim of this study was to evaluate the ability of Helicobacter pylori eradication treatment to increase platelet counts in Korean patients with chronic idiopathic thrombocytopenic purpura (ITP). METHODS: A... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?
-
Jeon HK, Kim GH
- KMID: 1786099
- J Korean Med Sci.
- 2014 May;29(5):619-620.
- doi: 10.3346/jkms.2014.29.5.619
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
-
Gong EJ, Yun SC, Jung HY, Lim H, Choi KS, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH
- KMID: 1786114
- J Korean Med Sci.
- 2014 May;29(5):704-713.
- doi: 10.3346/jkms.2014.29.5.704
Proton pump inhibitor (PPI)-based triple therapy consisting of PPI, amoxicillin, and clarithromycin, is the recommended first-line treatment for Helicobacter pylori infection. However, the eradication rate of triple therapy has declined... -
- CITED
-
- Close
- SHARE
-
- Close
